OpenGrowth: An Automated and Rational Algorithm for Finding New Protein Ligands
- PMID: 26356253
- DOI: 10.1021/acs.jmedchem.5b00886
OpenGrowth: An Automated and Rational Algorithm for Finding New Protein Ligands
Abstract
We present a new open-source software, called OpenGrowth, which aims to create de novo ligands by connecting small organic fragments in the active site of proteins. Molecule growth is biased to produce structures that statistically resemble drugs in an input training database. Consequently, the produced molecules have superior synthetic accessibility and pharmacokinetic properties compared with randomly grown molecules. The growth process can take into account the flexibility of the target protein and can be started from a seed to mimic R-group strategy or fragment-based drug discovery. Primary applications of the software on the HIV-1 protease allowed us to quickly identify new inhibitors with a predicted Kd as low as 18 nM. We also present a graphical user interface that allows a user to select easily the fragments to include in the growth process. OpenGrowth is released under the GNU GPL license and is available free of charge on the authors' website and at http://opengrowth.sourceforge.net/ .
Similar articles
-
CONCERTS: dynamic connection of fragments as an approach to de novo ligand design.J Med Chem. 1996 Apr 12;39(8):1651-63. doi: 10.1021/jm950792l. J Med Chem. 1996. PMID: 8648605
-
Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.J Mol Graph Model. 2015 Mar;56:20-30. doi: 10.1016/j.jmgm.2014.11.015. Epub 2014 Dec 5. J Mol Graph Model. 2015. PMID: 25541527
-
Efficient molecular docking of NMR structures: application to HIV-1 protease.Protein Sci. 2007 Jan;16(1):43-51. doi: 10.1110/ps.062501507. Epub 2006 Nov 22. Protein Sci. 2007. PMID: 17123961 Free PMC article.
-
Multiple Target Drug Design Using LigBuilder 3.Methods Mol Biol. 2021;2266:279-298. doi: 10.1007/978-1-0716-1209-5_16. Methods Mol Biol. 2021. PMID: 33759133
-
HIV-1 protease folding and the design of drugs which do not create resistance.Curr Opin Struct Biol. 2008 Feb;18(1):60-6. doi: 10.1016/j.sbi.2007.10.004. Epub 2007 Dec 21. Curr Opin Struct Biol. 2008. PMID: 18160276 Review.
Cited by
-
CReM: chemically reasonable mutations framework for structure generation.J Cheminform. 2020 Apr 22;12(1):28. doi: 10.1186/s13321-020-00431-w. J Cheminform. 2020. PMID: 33430959 Free PMC article.
-
Structure of PDE3A-SLFN12 complex and structure-based design for a potent apoptosis inducer of tumor cells.Nat Commun. 2021 Oct 27;12(1):6204. doi: 10.1038/s41467-021-26546-8. Nat Commun. 2021. PMID: 34707099 Free PMC article.
-
Evaluation of anti-cancer and anti-covid-19 properties of cationic pentapeptide Glu-Gln-Arg-Pro-Arg, from rice bran protein and its d-isomer analogs through molecular docking simulations.J Mol Graph Model. 2021 Nov;108:107999. doi: 10.1016/j.jmgm.2021.107999. Epub 2021 Jul 31. J Mol Graph Model. 2021. PMID: 34352727 Free PMC article.
-
Demonstration of AutoDock as an Educational Tool for Drug Discovery.J Chem Educ. 2017 Mar 14;94(3):345-349. doi: 10.1021/acs.jchemed.6b00555. Epub 2017 Feb 13. J Chem Educ. 2017. PMID: 28670004 Free PMC article.
-
A flexible data-free framework for structure-based de novo drug design with reinforcement learning.Chem Sci. 2023 Oct 19;14(43):12166-12181. doi: 10.1039/d3sc04091g. eCollection 2023 Nov 8. Chem Sci. 2023. PMID: 37969589 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources